Key result
Higher atherogenic index of plasma links to ~141% higher odds of obstructive CAD in NSTEMI.
Why the study?
The atherogenic index of plasma (AIP) and inflammatory indices may reflect the burden of atherosclerosis, but their predictive value for obstructive CAD in NSTEMI patients required evaluation.
Do atherogenic and inflammatory biomarkers predict obstructive coronary artery disease in patients with NSTEMI?
Observational (n=624)
Do atherogenic and inflammatory biomarkers predict obstructive coronary artery disease in patients with NSTEMI?
Odds Ratio: 2.413
p-value: p=<0.05
Atherogenic index of plasma and inflammatory markers are independently associated with obstructive coronary artery disease in NSTEMI patients, though their standalone discriminative ability varies.
AIP may support NSTEMI risk stratification yet modest AUC warrants caution; leaves open incremental value over NLR in prospective cohorts.
Background The atherogenic index of plasma (AIP) and inflammatory indices may reflect the burden of atherosclerosis. This study evaluated their predictive value for obstructive coronary artery disease (CAD) in patients with non-ST-elevation myocardial infarction (NSTEMI).Methods This retrospective study included 624 NSTEMI patients undergoing coronary angiography. Patients were classified as having obstructive or non-obstructive CAD. Demographic, clinical, laboratory, and echocardiographic characteristics were compared. Independent predictors were identified using multivariable logistic regression, and discriminative performance was assessed by receiver operating characteristic analysis.Results The obstructive CAD group was significantly older (64.3 ± 12.3 vs. 57.4 ± 14.2 years; p < 0.001) with higher prevalence of males (63.3% vs. 50.8%; p = 0.003), hypertension (52.1% vs. 30.2%; p < 0.001), and diabetes mellitus (47.6% vs. 28.9%; p < 0.001). Inflammatory markers were markedly elevated: NLR [4.2 vs. 1.9; p < 0.001], PLR [140.9 vs. 119.1; p < 0.001], SII [1113.3 vs. 520.1; p < 0.001], and CRP [0.4 vs. 0.2 mg/dL; p < 0.001]. AIP was significantly higher [0.71 vs. 0.46; p < 0.001]. ROC analysis demonstrated that NLR (AUC = 0.764) and SII (AUC = 0.738) had the highest discriminative ability, while AIP showed limited performance (AUC = 0.563). In multivariable analysis, independent predictors included age (OR = 1.031), hypertension (OR = 1.645), diabetes (OR = 1.547), PLR (OR = 1.004), CRP (OR = 1.156), and AIP (OR = 2.413; all p < 0.05).Conclusion AIP was independently associated with obstructive CAD beyond traditional risk factors and inflammatory indices, despite modest standalone discriminative ability. These findings are hypothesis-generating and require prospective validation with clinical outcomes before routine clinical implementation.
No takes yet. Share an insight, caveat, or question.
Can et al. (2026) conducted an observational in NSTEMI (n=624). Atherogenic index of plasma (AIP) was evaluated on Obstructive coronary artery disease (OR 2.413, p=<0.05). The atherogenic index of plasma was independently associated with obstructive coronary artery disease in NSTEMI patients (OR 2.413; P<0.05), despite modest standalone discriminative ability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: